Seq2Saccharide: Unlocking Hidden Antibiotics with AI, Genomics, and Mass Spectrometry

Seq2Saccharide: A New Era for Antibiotic Discovery

Antibiotic resistance is one of the greatest health challenges of our time. As pathogens outsmart our existing drugs, the hunt for novel antibiotics has never been more urgent. Among the most promising candidates are oligosaccharides and aminoglycosides—powerful natural products that have served as life-saving antibiotics for decades. Yet, discovering new ones has traditionally been a slow and costly process.

That is where Seq2Saccharide, a cutting-edge computational tool, comes in. By fusing genome mining and computational mass spectrometry, Seq2Saccharide offers a breakthrough approach for rapidly identifying saccharide-based natural products hidden in microbial genomes.

How Seq2Saccharide Works

1. Genome Mining for Biosynthetic Gene Clusters (BGCs):
   Seq2Saccharide scans microbial DNA for saccharide-producing genes.
2. Probabilistic Prediction of Monomers:
   It predicts potential sugar building blocks (monomers) encoded in these clusters.
3. Backbone Assembly & Post-modifications:
   Using rules of saccharide biosynthesis, it models possible molecular backbones and integrates enzymatic modifications.
4. Mass Spectral Matching:
   Candidate structures are validated by comparing them against experimental LC-MS/MS spectra, filtering out false predictions.

Why This Matters

• Accuracy Boost: Seq2Saccharide outperforms existing tools like antiSMASH and PRISM in predicting saccharide structures.
• Scalable Discovery: It can screen massive genomic and metabolomic datasets simultaneously.
• Real Discoveries: The tool successfully identified known antibiotics such as streptomycin, neomycin, and kanamycin, and even uncovered a biosynthetic gene cluster for trestatin B, a potent α-amylase inhibitor.

This means researchers now have a powerful engine to explore microbial dark matter and unlock new antibiotics critical in the fight against multidrug-resistant infections.

The Bigger Picture

Oligosaccharides and aminoglycosides are more than just antibiotics. They play key roles in agriculture, veterinary medicine, and biotechnology. With Seq2Saccharide, scientists can accelerate discoveries that improve human health, food security, and industrial innovation.

By bridging the gap between vast genomic data and experimental chemistry, Seq2Saccharide exemplifies how AI-driven science is reshaping drug discovery.

Reference

Yan, D., Behsaz, B., Li, Y., Wang, X., Skala, L., Liu, S., Lew, H. W., Guler, M., Jayaprakash, H., & Zhou, M. (2025). Seq2Saccharide: Discovering Oligosaccharides and Aminoglycosides Natural Products by Integrating Computational Mass Spectrometry and Genome Mining. Journal of the American Chemical Society.

Share

Related posts:

Red Sea Streptomyces Reveals New Bioactive Metabolites through Genomic and Metabolomic Integration New Class of Antibiotics with a Novel Mode of Inhibition against World Health Organization’s Critical Listed Bacteria, Carbapenem-Resistant Acinetobacter baumannii Scope and Applications of Bioinformatics Smart Biosensors: Dual ACE2 Epitope Receptors Offer Rapid Detection of SARS-CoV Variants Earthworm Gut Bacteria Offers Sustainable Solution Against Rice Bacterial Blight